Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 Helius Medical Technologies just launched a $1.25 billion SOL treasury. Solana treasury strategies already hold 1.2% of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Series A Led by Foundation Capital, with Participation from Reciprocal Ventures, 6th Man Ventures, Chapter One, Propel, and Solana Ecosystem Founders TORONTO--(BUSINESS WIRE)--Helius, a vertically ...

Helius Minerals Limited ("Helius" or the "Company") (TSXV: HHH) notes the recent statements issued by Phoenix Gems, a U.S. company, through Brent Evan Smith, concerning a civil dispute involving ...

Helius Medical Technologies Inc (NASDAQ:HSDT) shares are trading higher after the Centers for Medicare & Medicaid Services assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes ...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe.

VANCOUVER, BC, May 12, 2026 /CNW/ - Helius Minerals Limited ("Helius" or the "Company") (TSXV: HHH) is pleased to advise that it has appointed Leigh Junk as an Independent Non-Executive Director of ...

A user inquired why Solana over Zcash, which has risen more than 1,054% in a year amid increasing privacy-coin interest and a reported Multicoin Capital investment.

VANCOUVER BC, May 9, 2025 /CNW/ - Helius Minerals Limited (" Helius" or the " Company") (TSXV: HHH) is pleased to announce that the shareholders of Colossus Minerals Inc. (" Colossus") at the special ...

Helius Medical Technologies announced compliance with Nasdaq's bid price requirement while working on equity rule compliance by June 30, 2025. Helius Medical Technologies, Inc. announced that it has ...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe.